Bruno Wohlschlegel
Amministratore Delegato presso APONTIS PHARMA AG
Profilo
Bruno Wohlschlegel is currently the Chief Executive Officer at APONTIS PHARMA AG and APONTIS PHARMA Deutschland GmbH & Co. KG.
Posizioni attive di Bruno Wohlschlegel
| Società | Posizione | Inizio |
|---|---|---|
| APONTIS PHARMA AG | Amministratore Delegato | - |
Apontis Pharma GmbH & Co. KG
 Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Amministratore Delegato | 01/09/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Aziende private | 1 |
|---|---|
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Health Technology |
- Borsa valori
- Insiders
- Bruno Wohlschlegel
